No significant differences in Galectin-9 and CD66a/c/d/e expression were detected among monocytes, CD4+ T cells, CD8+ T cells, NK cells, NKT cells and dendritic cells from T2DM and control study participants (Supplementary Figures S6A–D). This evidence concerns the gene CEACAM1 and type 2 diabetes mellitus.